• Profile
Close

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

European Journal of Gastroenterology & Hepatology Apr 04, 2019

Dissegna D, et al. - Predictors of hepatic encephalopathy (HE) development and cumulative transplant-free survival after transjugular intrahepatic portosystemic shunt (TIPS) placement in patients with cirrhosis complicated by refractory ascites and major gastroesophageal bleeding were investigated. Researchers examined 63 cirrhotic patients who underwent TIPS positioning as a secondary prophylaxis of major upper gastroesophageal bleeding (N=30) or to control refractory ascites (N=33). Outcomes suggest that for patients with cirrhosis and severe complications of portal hypertension that are not manageable with standard treatments, TIPS insertion could be viewed as a safe and effective treatment option. Interestingly, on confirming this in future studies, the addition of the history of spontaneous bacterial peritonitis pre-TIPS could be made to the model for end-stage liver disease score as a strong baseline predictor of post-TIPS mortality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay